Related Experiment Videos
Perillyl Alcohol Inhibits Breast Cell Migration without Affecting Cell Adhesion
Journal of Biomedicine & Biotechnology
|December 19, 2002
Summary
Perillyl alcohol, a d-limonene derivative, shows promise as a non-toxic breast cancer inhibitor by reducing cell migration and growth. Subtoxic doses may offer prophylactic benefits.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- The monoterpene d-limonene has demonstrated chemotherapeutic and chemopreventive effects in breast cancer.
- Investigating derivatives of d-limonene for novel therapeutic applications is crucial.
Purpose of the Study:
- To screen for non-toxic inhibitors of breast cancer cell migration.
- To evaluate the efficacy and toxicity of d-limonene and its related compounds: perillyl alcohol and perillyl aldehyde.
Main Methods:
- Utilized the non-tumorigenic human breast cell line MCF-10A to assess compound toxicity and cell migration inhibition.
- Tested adhesion to fibronectin using MCF-10A and MDA-MB 435 cell lines.
- Assessed the impact of perillyl alcohol on MDA-MB 435 cell growth.
Main Results:
- Perillyl aldehyde was the most toxic, followed by perillyl alcohol, with d-limonene being the least toxic.
- A non-cytotoxic concentration of 0.5 mmol/L perillyl alcohol inhibited cell migration, whereas d-limonene did not.
- Perillyl alcohol at 0.4 mmol/L inhibited MDA-MB 435 cell growth, but higher concentrations for migration inhibition proved toxic.
Conclusions:
- Subtoxic doses of perillyl alcohol demonstrate potential as prophylactic agents in breast cancer treatment.
- Perillyl alcohol exhibits selective anti-migratory and anti-proliferative effects on breast cancer cells.
- Further research into perillyl alcohol's therapeutic potential is warranted.